Literature DB >> 3956564

Phenprocoumon metabolites in human plasma; characterization by HPLC and GC-MS.

J X de Vries, R Zimmermann, J Harenberg.   

Abstract

Pooled plasma from patients receiving phenprocoumon anticoagulant therapy was extracted and the following substances were characterized: phenprocoumon, and its 7-hydroxy,4'-hydroxy and 6-hydroxy derivatives; they were identified by HPLC and after methylation by quartz capillary GC-MS using the electron impact and selective ion monitoring modes. This is the first occasion when phenprocoumon metabolites have been identified in plasma; they were unconjugated and in much lower concentrations (43.2 and 2 ng/ml for the 7,4' and 6-hydroxy derivatives, respectively) than the original compound (2000 ng/ml).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3956564     DOI: 10.1007/bf00635898

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  A stable isotope assay for phenprocoumon and its metabolites.

Authors:  L D Heimark; W F Trager
Journal:  Biomed Mass Spectrom       Date:  1985-02

2.  Absolute configurations of the four warfarin alcohols.

Authors:  K K Chan; R J Lewis; W F Trager
Journal:  J Med Chem       Date:  1972-12       Impact factor: 7.446

3.  The metabolic fate of warfarin: studies on the metabolites in plasma.

Authors:  R J Lewis; W F Trager
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

4.  Mass spectral analysis in the identification of human metabolites of warfarin.

Authors:  W F Trager; R J Lewis; W A Garland
Journal:  J Med Chem       Date:  1970-11       Impact factor: 7.446

5.  Changes in the metabolic profiles of R- and S-warfarin and R- and S-phenprocoumon as a probe to categorize the effect of inducing agents on microsomal hydroxylases.

Authors:  W R Porter; C Wheeler; W F Trager
Journal:  Biochem Pharmacol       Date:  1981-11-15       Impact factor: 5.858

6.  Stereochemical aspects of the metabolism of phenprocoumon in rat liver microsomes.

Authors:  C Wheeler; W F Trager; W R Porter
Journal:  Biochem Pharmacol       Date:  1981-07-01       Impact factor: 5.858

7.  Biotransformation of phenprocoumon in the rat.

Authors:  L R Pohl; R E Haddock; W F Trager
Journal:  J Med Chem       Date:  1975-05       Impact factor: 7.446

8.  Determination of the anticoagulant phenprocoumon in human plasma and urine by high-performance liquid chromatography.

Authors:  J X De Vries; J Harenberg; E Walter; R Zimmermann; M Simon
Journal:  J Chromatogr       Date:  1982-08-13

9.  Identification of phenprocoumon metabolites in human urine by high-performance liquid chromatography and gas chromatography-mass spectrometry.

Authors:  J X De Vries; M Simon; R Zimmermann; J Harenberg
Journal:  J Chromatogr       Date:  1985-03-22

10.  Metabolic fate of phenprocoumon in humans.

Authors:  S Toon; L D Heimark; W F Trager; R A O'Reilly
Journal:  J Pharm Sci       Date:  1985-10       Impact factor: 3.534

View more
  4 in total

Review 1.  Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.

Authors:  Mike Ufer
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon.

Authors:  H Mönig; C Baese; H T Heidemann; E E Ohnhaus; H M Schulte
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

3.  Biliary excretion of phenprocoumon and metabolites.

Authors:  J X de Vries; R Raedsch; U Völker; I Walter-Sack; E Weber
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  The effects of frusemide and probenecid on the pharmacokinetics of phenprocoumon.

Authors:  H Mönig; M Böhm; E E Ohnhaus; W Kirch
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.